Abstract
Aims: The purpose of this study was to compare the diagnostic performance of an immunoassay for placental alpha microglobulin-1 (PAMG-1) in vaginal fluid with the intra-amniotic instillation of indigo carmine for the diagnosis of membrane rupture in patients with an equivocal status.
Methods: A prospective multi-site study was performed involving women reporting signs, symptoms, or complaints suggestive of rupture of membrane (ROM) between 21 and 42 weeks of gestation without obvious leakage of fluid from the cervical os during sterile speculum examination and without confirmation of ROM by traditional methods.
Results: A total of 140 patients were recruited with a prevalence of ROM of 19.3%. The PAMG-1 test had a sensitivity of 100.0% [confidence interval (CI) 0.87–1.0], specificity of 99.1% [(CI) 0.95–0.99], positive predictive value of 96.3% [(CI) 0.82–0.99], negative predictive value of 100.0% [(CI) 0.97–1.0], and ± likelihood ratios of 74.6 [(CI) 20.31–274.51] and 0.0 [(CI) 0.00–0.98].
Conclusions: The PAMG-1 immunoassay in vaginal fluid yielded results that were comparable to those of the instillation of indigo carmine into the amniotic cavity; therefore, we propose that PAMG-1 is a sensitive and specific test to assess ROM in patients with an equivocal diagnosis based on simple tests. This finding prompts consideration for the use of the noninvasive PAMG-1 test in situations where the use of the invasive dye test is not practical.
Acknowledgements
We would like to thank AmniSure International, LLC for providing the PAMG-1 immunoassay tests free of charge and for delivering the kits to the different countries.
References
[1] Albayrak M, Ozdemir I, Koc O, Ankarali H, Ozen O. Comparison of the diagnostic efficacy of the two rapid bedside immunoassays and combined clinical conventional diagnosis in prelabour rupture of membranes. Eur J Obstet Gynecol Reprod Biol. 2011;158:179–82.10.1016/j.ejogrb.2011.04.041Search in Google Scholar
[2] Anai T, Tanaka Y, Hirota Y, Miyakawa I. Vaginal fluid hCG levels for detecting premature rupture of membranes. Obstet Gynecol. 1997;89:261–4.10.1016/S0029-7844(96)00448-6Search in Google Scholar
[3] Atlay RD, Sutherst JR. Premature rupture of the fetal membranes confirmed by intra-amniotic injection of dye (Evans blue T-1824). Am J Obstet Gynecol. 1970;108:993–4.10.1016/0002-9378(70)90351-0Search in Google Scholar
[4] Atterbury JL, Groome LJ, Hoff C. Methods used to diagnose premature rupture of membranes: a national survey of 812 obstetric nurses. Obstet Gynecol. 1998;92:384–9.10.1097/00006250-199809000-00013Search in Google Scholar
[5] Beckmann MW, Wiegratz I, Dereser MM, Baier P, Born HJ. [Diagnosis of rupture of fetal membranes: comparison of vaginal detection of fetal fibronectin and intra-amnion injection of indigo carmine]. Geburtshilfe Frauenheilkd. 1993;53:86–91.10.1055/s-2007-1023643Search in Google Scholar
[6] Birkenmaier A, Ries JJ, Kuhle J, Burki N, Lapaire O, Hosli I. Placental alpha-microglobulin-1 to detect uncertain rupture of membranes in a European cohort of pregnancies. Arch Gynecol Obstet. 2012;285:21–5.10.1007/s00404-011-1895-9Search in Google Scholar
[7] Buyukbayrak EE, Turan C, Unal O, Dansuk R, Cengizoglu B. Diagnostic power of the vaginal washing-fluid prolactin assay as an alternative method for the diagnosis of premature rupture of membranes. J Matern Fetal Neonatal Med. 2004;15:120–5.10.1080/14767050410001659842Search in Google Scholar
[8] Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol. 2008;1:11–22.Search in Google Scholar
[9] Cousins LM, Smok DP, Lovett SM, Poeltler DM. AmniSure placental alpha microglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes. Am J Perinatol. 2005;22:317–20.10.1055/s-2005-870896Search in Google Scholar
[10] Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore T, Greene MF. Maternal-fetal medicine. 7th ed. Philadelphia, PA: Saunders; 2013.Search in Google Scholar
[11] de Haan HH, Offermans PM, Smits F, Schouten HJ, Peeters LL. Value of the fern test to confirm or reject the diagnosis of ruptured membranes is modest in nonlaboring women presenting with nonspecific vaginal fluid loss. Am J Perinatol. 1994;11:46–50.10.1055/s-2007-994535Search in Google Scholar
[12] El-Messidi A, Cameron A. Diagnosis of premature rupture of membranes: inspiration from the past and insights for the future. J Obstet Gynaecol Can. 2010;32:561–9.10.1016/S1701-2163(16)34525-XSearch in Google Scholar
[13] Erdemoglu E, Mungan T. Significance of detecting insulin-like growth factor binding protein-1 in cervicovaginal secretions: comparison with nitrazine test and amniotic fluid volume assessment. Acta Obstet Gynecol Scand. 2004;83:622–6.10.1111/j.0001-6349.2004.00343.xSearch in Google Scholar
[14] Esim E, Turan C, Unal O, Dansuk R, Cengizglu B. Diagnosis of premature rupture of membranes by identification of beta-HCG in vaginal washing fluid. Eur J Obstet Gynecol Reprod Biol. 2003;107:37–40.10.1016/S0301-2115(02)00277-4Search in Google Scholar
[15] Fujimoto S, Kishida T, Sagawa T, Negishi H, Okuyama K, Hareyama H, et al. Clinical usefulness of the dye-injection method for diagnosing premature rupture of the membranes in equivocal cases. J Obstet Gynaecol (Tokyo 1995). 1995;21: 215–20.10.1111/j.1447-0756.1995.tb01000.xSearch in Google Scholar
[16] Gungorduk K, Asicioglu O, Besimoglu B, Gungorduk OC, Yildirm G, Ark C, et al. Labor induction in term premature rupture of membranes: comparison between oxytocin and dinoprostone followed 6 hours later by oxytocin. Am J Obstet Gynecol. 2012;206:60–8.10.1016/j.ajog.2011.07.035Search in Google Scholar
[17] Jeurgens-Borst AJ, Bekkers RL, Sporken JM, van den Berg PP. Use of insulin like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Eur J Obstet Gynecol Reprod Biol. 2002;102:11–4.10.1016/S0301-2115(01)00560-7Search in Google Scholar
[18] Kishida T, Yamada H, Negishi H, Sagawa T, Makinoda S, Fujimoto S. Diagnosis of premature rupture of the membranes in preterm patients, using an improved AFP kit: comparison with ROM-check and/or nitrazine test. Eur J Obstet Gynecol Reprod Biol. 1996;69:77–82.10.1016/0301-2115(95)02519-7Search in Google Scholar
[19] Kurdoglu M, Kolusari A, Adali E, Yildizhan R, Kurdoglu Z, Kucukaydin Z, et al. Does residual amniotic fluid after preterm premature rupture of membranes have an effect on perinatal outcomes? 12 years experience of a tertiary care center. Arch Gynecol Obstet. 2010;281:601–7.10.1007/s00404-009-1147-4Search in Google Scholar PubMed
[20] Lee SE, Park JS, Norwitz ER, Kim KW, Park HS, Jun JK. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol. 2007;109:634–40.10.1097/01.AOG.0000252706.46734.0aSearch in Google Scholar PubMed
[21] Lee SM, Romero R, Park JW, Kim SM, Park CW, Korzeniewski SJ, et al. The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes. J Matern Fetal Neonatal Med. 2012;25:1690–8.10.3109/14767058.2012.657279Search in Google Scholar PubMed PubMed Central
[22] Magann EF, Sandlin AT, Ounpraseuth ST. Amniotic fluid and the clinical relevance of the sonographically estimated amniotic fluid volume: oligohydramnios. J Ultrasound Med. 2011;30:1573–85.10.7863/jum.2011.30.11.1573Search in Google Scholar PubMed
[23] Mariona FG, Cabero L. Are we ready for a new look at the diagnosis of premature rupture of membranes? J Matern Fetal Neonatal Med. 2012;25:403–7.10.3109/14767058.2011.581715Search in Google Scholar PubMed
[24] Neil PR, Wallace EM. Is Amnisure(R) useful in the management of women with prelabour rupture of the membranes? Aust NZ J Obstet Gynaecol. 2010;50:534–8.10.1111/j.1479-828X.2010.01238.xSearch in Google Scholar PubMed
[25] Nisell H, Hagskog K, Westgren M. Assessment of fetal fibronectin in cervical secretion in cases of equivocal rupture of the membranes at term. Acta Obstet Gynecol Scand. 1996;75:132–4.10.3109/00016349609033304Search in Google Scholar PubMed
[26] Park HS, Ahn BJ, Kwan JJ. Placental transfer of clarithromycin in human pregnancies with preterm premature rupture of membranes. J Perinat Med. 2012;40:641–6.10.1515/jpm-2012-0038Search in Google Scholar PubMed
[27] Piazze J, Anceschi MM, Cerekja A, Brunelli R, Meloni P, Marzano S, et al. Validity of amniotic fluid index in preterm rupture of membranes. J Perinat Med. 2007;35:394–8.10.1515/JPM.2007.077Search in Google Scholar PubMed
[28] Practice Bulletins No. 139. Premature rupture of membranes. Obstet Gynecol. 2013;122:918–30.10.1097/01.AOG.0000435415.21944.8fSearch in Google Scholar PubMed
[29] Ramsauer B, Vidaeff AC, Hosli I, Park JS, Strauss A, Khodjaeva Z, et al. The diagnosis of rupture of fetal membranes (ROM): a meta-analysis. J Perinat Med. 2013;41:233–40.10.1515/jpm-2012-0247Search in Google Scholar PubMed
[30] Schmidt R, Rabe D, Leucht W, Schmidt W. [Amniocentesis following premature rupture of fetal membranes and suspected premature rupture of fetal membranes in late pregnancy]. Geburtshilfe Frauenheilkd. 1988;48:29–31.10.1055/s-2008-1035690Search in Google Scholar PubMed
[31] Tagore S, Kwek K. Comparative analysis of insulin-like growth factor binding protein-1 (IGFBP-1), placental alpha-microglobulin-1 (PAMG-1) and nitrazine test to diagnose premature rupture of membranes in pregnancy. J Perinat Med. 2010;38:609–12.10.1515/jpm.2010.099Search in Google Scholar PubMed
[32] van der Ham DP, van Melick MJ, Smits L, Nijhuis JG, Weiner CP, van Beek JH, et al. Methods for the diagnosis of rupture of the fetal membranes in equivocal cases: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2011;157:123–7.10.1016/j.ejogrb.2011.03.006Search in Google Scholar PubMed
[33] van der Ham DP, van Teeffelen AS, Mol BW. Prelabour rupture of membranes: overview of diagnostic methods. Curr Opin Obstet Gynecol. 2012;24:408–12.10.1097/GCO.0b013e328359825cSearch in Google Scholar PubMed
[34] Wang T, Zhou R, Xiong W, Wang Y, Zhu C, Song C, et al. Clinical evaluation of soluble intercellular adhesion molecule-1 and insulin like growth factor-binding protein-1-based rapid immunoassays for the diagnosis of prelabor rupture of membranes. J Perinat Med. 2013;41:181–5.10.1515/jpm-2012-0094Search in Google Scholar PubMed
[35] Watanabe T, Minakami H, Itoi H, Sato I, Sakata Y, Tamada T. Evaluation of latex agglutination test for alpha-fetoprotein in diagnosing rupture of fetal membranes. Gynecol Obstet Invest. 1995;39:15–8.10.1159/000292368Search in Google Scholar PubMed
[36] Weissmann-Brenner A, O’Reilly-Green C, Ferber A, Divon MY. Values of amniotic fluid index in cases of preterm premature rupture of membranes. J Perinat Med. 2009;37:232–5.10.1515/JPM.2009.078Search in Google Scholar PubMed
The authors stated that there are no conflicts of interest regarding the publication of this article.
©2014 by De Gruyter
